Does Abbott Laboratories's CEO Salary Compare Well With Others?

雅培(Abbott)公司首席执行官的薪水与其他人相比好吗?

2019-09-04 18:58:55 YAHOO!FINANCE

本文共1180个字,阅读需3分钟

Miles White has been the CEO of Abbott Laboratories since 1999. First, this article will compare CEO compensation with compensation at other large companies. After that, we will consider the growth in the business. And finally - as a second measure of performance - we will look at the returns shareholders have received over the last few years. This process should give us an idea about how appropriately the CEO is paid. Check out our latest analysis for Abbott Laboratories According to our data, Abbott Laboratories has a market capitalization of US$149b, and pays its CEO total annual compensation worth US$24m. (This figure is for the year to December 2018). We think total compensation is more important but we note that the CEO salary is lower, at US$1.9m. We took a group of companies with market capitalizations over US$8.0b, and calculated the median CEO total compensation to be US$11m. There aren't very many mega-cap companies, so we had to take a wide range to get a meaningful comparison figure. Thus we can conclude that Miles White receives more in total compensation than the median of a group of large companies in the same market as Abbott Laboratories. However, this doesn't necessarily mean the pay is too high. A closer look at the performance of the underlying business will give us a better idea about whether the pay is particularly generous. The graphic below shows how CEO compensation at Abbott Laboratories has changed from year to year. On average over the last three years, Abbott Laboratories has grown earnings per share (EPS) by 14% each year (using a line of best fit). It achieved revenue growth of 4.6% over the last year. Overall this is a positive result for shareholders, showing that the company has improved in recent years. It's also good to see modest revenue growth, suggesting the underlying business is healthy. Shareholders might be interested in this free visualization of analyst forecasts. Boasting a total shareholder return of 112% over three years, Abbott Laboratories has done well by shareholders. This strong performance might mean some shareholders don't mind if the CEO were to be paid more than is normal for a company of its size. We examined the amount Abbott Laboratories pays its CEO, and compared it to the amount paid by other large companies. As discussed above, we discovered that the company pays more than the median of that group. Importantly, though, the company has impressed with its earnings per share growth, over three years. On top of that, in the same period, returns to shareholders have been great. So, considering this good performance, the CEO compensation may be quite appropriate. Whatever your view on compensation, you might want to check if insiders are buying or selling Abbott Laboratories shares (free trial). Important note: Abbott Laboratories may not be the best stock to buy. You might find something better in this list of interesting companies with high ROE and low debt. We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.
迈尔斯·怀特自1999年以来一直担任雅培(Abbott)公司的首席执行官。首先,本文将 CEO 薪酬与其他大公司的薪酬进行比较。之后,我们将考虑业务的增长。最后,作为第二个衡量业绩的指标,我们将考察股东在过去几年获得的回报。这个过程应该让我们了解 CEO 的薪酬是如何恰当的。 查看我们对雅培(Abbott)实验室的最新分析 根据我们的数据,雅培(Abbott)公司市值为1490亿美元,向首席执行官支付的年度报酬总额为2400万美元。(此数字为截至2018年12月的年度)。我们认为总薪酬更重要,但我们注意到 CEO 的薪酬较低,为190万美元。我们选取了一批市值超过80亿美元的公司,计算 CEO 薪酬中值为1100万美元。没有太多的巨型公司,所以我们必须采取广泛的范围来获得一个有意义的比较数字。 因此,我们可以得出结论, Miles White 获得的总薪酬高于与雅培(Abbott)公司相同市场的一组大公司的中位数。然而,这并不一定意味着薪水太高。更仔细地审视基础业务的表现,会让我们更好地了解薪酬是否特别慷慨。 下面的图表显示了雅培(Abbott)公司 CEO 薪酬的年复一年的变化。 在过去三年中,雅培(Abbott)公司的每股收益( EPS )平均每年增长14%(使用最适合的一条线)。公司去年实现收入增长4.6%。 总体而言,这对股东是一个积极的结果,表明公司近年来有所改善。同时,看到适度的收入增长也是件好事,这表明基础业务是健康的。股东可能对分析师预测的这种免费可视化感兴趣。 三年来,雅培(Abbott)公司实现了112%的股东总回报,股东表现良好。这种强劲的业绩可能意味着,一些股东不介意首席执行官的薪酬是否高于其规模的公司的正常水平。 我们检查了雅培(Abbott)公司支付给 CEO 的金额,并与其他大公司支付的金额进行了比较。如上所述,我们发现公司支付的金额高于该集团的中位数。 不过,重要的是,该公司三年来的每股收益增长令人印象深刻。此外,在同一时期,回报股东是很大的。因此,考虑到这一良好的业绩, CEO 的薪酬可能相当合适。无论你对薪酬的看法如何,你都可能想看看内部人士是否在买卖雅培(Abbott)公司的股票(免费试用)。 重要提示:雅培(Abbott)制药可能不是最好的股票购买。你可能会发现一些更好的公司在这份名单上的高净资产收益率和低负债。 我们的目标是为您带来长期的重点研究分析驱动的基础数据。请注意,我们的分析可能不会考虑最新的价格敏感的公司公告或定性材料。如果您发现需要更正的错误,请联系编辑团队@ simplywalst.com 。本文由 SimpleWallSt 撰写,性质一般。它不构成购买或出售任何股票的建议,也不考虑你的目标,或你的财务状况。简单地说,华尔街在上述股票中没有任何地位。谢谢你的阅读。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文